Table 2 Relationship between BCL2 level and clinicopathologic features (N = 115)
From: Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression
Characteristics | No. of Patients | BCL2 ΔCta Mean ± SD | P value | |
|---|---|---|---|---|
No. | % | |||
Age (years) | ||||
 ≥ 60 | 53 | 46.1 | 5.475 ± 3.733 | 0.5450 |
 <  60 | 62 | 53.9 | 4.974 ± 3.584 | |
Gender | ||||
 Male | 82 | 71.3 | 5.108 ± 3.992 | 0.7880 |
 Female | 33 | 28.7 | 5.445 ± 2.631 | |
Smoking history | ||||
 Nonsmoker | 76 | 66.1 | 5.313 ± 3.353 | 0.8890 |
 Smoker | 39 | 33.9 | 4.994 ± 4.196 | |
Alcohol history | ||||
 Nondrinker | 82 | 71.3 | 5.404 ± 3.420 | 0.6564 |
 Drinker | 33 | 28.7 | 4.710 ± 4.196 | |
Tumor size (cm) | ||||
 ≤ 4 | 89 | 77.4 | 4.682 ± 3.567 | 0.0168 |
 >  4 | 26 | 22.6 | 6.994 ± 3.393 | |
Lymph node metastasis | ||||
 Non-metastasis | 63 | 54.8 | 5.096 ± 3.713 | 0.7979 |
 Metastasis | 52 | 45.2 | 5.337 ± 3.594 | |
TNM stage | ||||
 I | 69 | 60.0 | 5.835 ± 2.991 | 0.3083 |
 II | 41 | 35.7 | 4.282 ± 3.924 | |
 III | 5 | 4.3 | 5.972 ± 3.650 | |
Pathological Differentiation | ||||
 Well | 78 | 67.8 | 4.834 ± 3.916 | 0.1040 |
 Moderately/poorly | 37 | 32.2 | 5.986 ± 2.891 | |
Disease Site | ||||
 Tongue | 42 | 36.5 | 4.654 ± 4.016 | 0.1607 |
 Gingival | 36 | 31.3 | 6.024 ± 3.281 | |
 Cheek | 18 | 15.7 | 5.948 ± 4.205 | |
 Floor of Mouth | 12 | 10.4 | 4.743 ± 2.077 | |
 Oropharynx | 7 | 6.1 | 3.180 ± 2.684 | |